Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,354 public trials 2,837 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

NCT02180724

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Research Site Santa Barbara, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Minneapolis, Minnesota, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM

NCT07150091

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
  • GSK Investigational Site São Paulo, Brazil
  • GSK Investigational Site Halifax, Nova Scotia, Canada
View Trial Details
Active, Not Recruiting

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

NCT05653219

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • NorthShore University Health System Evanston, Illinois, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT05653349

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Community Cancer Institute Clovis, California, United States
  • Compassionate Care Res Group Inc Fountain Valley, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
View all 111 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

NCT06045689

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 0051 Los Alamitos, California, United States
  • Local Institution - 0033 New Haven, Connecticut, United States
  • Local Institution - 0055 St. Petersburg, Florida, United States
  • Local Institution - 0056 Wellington, Florida, United States
View all 52 locations
View Trial Details

Related conditions